Literature DB >> 15161747

Role of adipocyte-derived factors in enhancing insulin signaling in skeletal muscle and white adipose tissue of mice lacking Acyl CoA:diacylglycerol acyltransferase 1.

Hubert C Chen1, Meghana Rao, Mini P Sajan, Mary Standaert, Yoshinori Kanoh, Atsushi Miura, Robert V Farese, Robert V Farese.   

Abstract

Mice that lack acyl CoA:diacylglycerol acyltransferase 1 (DGAT1), a key enzyme in mammalian triglyceride synthesis, have decreased adiposity and increased insulin sensitivity. Here we show that insulin-stimulated glucose transport is increased in the skeletal muscle and white adipose tissue (WAT) of chow-fed DGAT1-deficient mice. This increase in glucose transport correlated with enhanced insulin-stimulated activities of phosphatidylinositol 3-kinase, protein kinase B (or Akt), and protein kinase Clambda (PKC-lambda), three key molecules in the insulin-signaling pathway, and was associated with decreased levels of serine-phosphorylated insulin receptor substrate 1 (IRS-1), a molecule implicated in insulin resistance. Similar findings in insulin signaling were also observed in DGAT1-deficient mice fed a high-fat diet. Interestingly, the increased PKC-lambda activity and decreased serine phosphorylation of IRS-1 were observed in chow-fed wild-type mice transplanted with DGAT1-deficient WAT, consistent with our previous finding that transplantation of DGAT1-deficient WAT enhances glucose disposal in wild-type recipient mice. Our findings demonstrate that DGAT1 deficiency enhances insulin signaling in the skeletal muscle and WAT, in part through altered expression of adipocyte-derived factors that modulate insulin signaling in peripheral tissues.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15161747     DOI: 10.2337/diabetes.53.6.1445

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  22 in total

Review 1.  Modulation of fatty acid metabolism as a potential approach to the treatment of obesity and the metabolic syndrome.

Authors:  Jun Kusunoki; Akio Kanatani; David E Moller
Journal:  Endocrine       Date:  2006-02       Impact factor: 3.633

2.  Pharmacological inhibition of diacylglycerol acyltransferase 1 reduces body weight gain, hyperlipidemia, and hepatic steatosis in db/db mice.

Authors:  Xiao-dong Zhang; Jian-wei Yan; Gui-rui Yan; Xiao-yun Sun; Jun Ji; Yi-ming Li; You-hong Hu; He-yao Wang
Journal:  Acta Pharmacol Sin       Date:  2010-11       Impact factor: 6.150

3.  DGAT1 deficiency decreases PPAR expression and does not lead to lipotoxicity in cardiac and skeletal muscle.

Authors:  Li Liu; Shuiqing Yu; Raffay S Khan; Gene P Ables; Kalyani G Bharadwaj; Yunying Hu; Lesley A Huggins; Jan W Eriksson; Linda K Buckett; Andrew V Turnbull; Henry N Ginsberg; William S Blaner; Li-Shin Huang; Ira J Goldberg
Journal:  J Lipid Res       Date:  2011-01-03       Impact factor: 5.922

4.  Discovery of a Potent and Selective DGAT1 Inhibitor with a Piperidinyl-oxy-cyclohexanecarboxylic Acid Moiety.

Authors:  Shuwen He; Qingmei Hong; Zhong Lai; David X Yang; Pauline C Ting; Jeffrey T Kuethe; Timothy A Cernak; Kevin D Dykstra; Donald M Sperbeck; Zhicai Wu; Yang Yu; Ginger X Yang; Tianying Jian; Jian Liu; Deodial Guiadeen; Arto D Krikorian; Lisa M Sonatore; Judyann Wiltsie; Jinqi Liu; Judith N Gorski; Christine C Chung; Jack T Gibson; JeanMarie Lisnock; Jianying Xiao; Michael Wolff; Sharon X Tong; Maria Madeira; Bindhu V Karanam; Dong-Ming Shen; James M Balkovec; Shirly Pinto; Ravi P Nargund; Robert J DeVita
Journal:  ACS Med Chem Lett       Date:  2014-09-08       Impact factor: 4.345

5.  Intestine-specific expression of acyl CoA:diacylglycerol acyltransferase 1 reverses resistance to diet-induced hepatic steatosis and obesity in Dgat1-/- mice.

Authors:  Bonggi Lee; Angela M Fast; Jiabin Zhu; Ji-Xin Cheng; Kimberly K Buhman
Journal:  J Lipid Res       Date:  2010-02-10       Impact factor: 5.922

6.  Effects of DGAT1 deficiency on energy and glucose metabolism are independent of adiponectin.

Authors:  Ryan S Streeper; Suneil K Koliwad; Claudio J Villanueva; Robert V Farese
Journal:  Am J Physiol Endocrinol Metab       Date:  2006-04-04       Impact factor: 4.310

7.  The critical role of atypical protein kinase C in activating hepatic SREBP-1c and NFkappaB in obesity.

Authors:  Mini P Sajan; Mary L Standaert; Sonali Nimal; Usha Varanasi; Tina Pastoor; Stephen Mastorides; Ursula Braun; Michael Leitges; Robert V Farese
Journal:  J Lipid Res       Date:  2009-02-06       Impact factor: 5.922

8.  Upregulation of myocellular DGAT1 augments triglyceride synthesis in skeletal muscle and protects against fat-induced insulin resistance.

Authors:  Li Liu; Yiying Zhang; Nancy Chen; Xiaojing Shi; Bonny Tsang; Yi-Hao Yu
Journal:  J Clin Invest       Date:  2007-05-17       Impact factor: 14.808

Review 9.  Beyond triglyceride synthesis: the dynamic functional roles of MGAT and DGAT enzymes in energy metabolism.

Authors:  Yuguang Shi; Dong Cheng
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-12-30       Impact factor: 4.310

Review 10.  Thematic review series: glycerolipids. DGAT enzymes and triacylglycerol biosynthesis.

Authors:  Chi-Liang Eric Yen; Scot J Stone; Suneil Koliwad; Charles Harris; Robert V Farese
Journal:  J Lipid Res       Date:  2008-08-29       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.